EcoDrugPlus

Ensembl ID : ENSCHYG00000023526
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSCHYG00000022990
Gene Symbol: -
Cross references: -
287 Possible Orthologues:

Ensembl ID : ENSCHYG00000022918
Gene Symbol: -
Cross references: -
149 Possible Orthologues:

Ensembl ID : ENSCHYG00000022903
Gene Symbol: -
Cross references: -
151 Possible Orthologues:

Ensembl ID : ENSCHYG00000022429
Gene Symbol: -
Cross references: -
348 Possible Orthologues:

Ensembl ID : ENSCHYG00000021751
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSCHYG00000021689
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSCHYG00000021670
Gene Symbol: -
Cross references: -
313 Possible Orthologues:

Ensembl ID : ENSCHYG00000021492
Gene Symbol: -
Cross references: -
378 Possible Orthologues:

Ensembl ID : ENSCHYG00000021342
Gene Symbol: -
Cross references: -
218 Possible Orthologues:

Ensembl ID : ENSCHYG00000021287
Gene Symbol: -
Cross references: -
222 Possible Orthologues:

Ensembl ID : ENSCHYG00000020589
Gene Symbol: -
Cross references: -
218 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).